IL284835A
(en )
2021-08-31
Pharmaceutical combination comprising tno155 and ribociclib
GB201807942D0
(en )
2018-06-27
Pharmaceutical formulation
EP3706741A4
(en )
2022-03-30
Pharmaceutical composition and use thereof
EP3434285A4
(en )
2019-10-30
Pharmaceutical composition and use thereof
IL273339A
(en )
2020-05-31
Griseofulvin compound and pharmaceutical use thereof
GB201709141D0
(en )
2017-07-26
Pharmaceutical formulation
ZA202102871B
(en )
2023-04-26
Pharmaceutical formulation
SG11202010124SA
(en )
2020-11-27
Stable pharmaceutical formulation
IL276323A
(en )
2020-09-30
4-methyldihydropyrimidinone compounds and pharmaceutical use thereof
IL278927A
(en )
2021-01-31
Pharmaceutical formulation
HK1250147A1
(en )
2018-11-30
A lyophilised pharmaceutical formulation and its use
IL279877A
(en )
2021-03-01
Ivosidenib forms and pharmaceutical compositions
FI3601277T3
(en )
2024-01-09
Pharmaceutical formulation
EP3497080A4
(en )
2020-07-29
Pharmaceutical formulations and their use
EP3851108C0
(en )
2023-08-09
Borate-based drug and use thereof
EP3647325A4
(en )
2021-03-17
Pharmaceutical composition comprising pcsk-9 antibody and use thereof
EP4069233A4
(en )
2024-03-13
Pharmaceutical combination and use thereof
ZA202100166B
(en )
2021-09-29
Composition comprising glycyrrhin and cosmetic and pharmaceutical uses thereof
IL282142A
(en )
2021-05-31
4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament
ZA202000959B
(en )
2021-08-25
Adamantylmethylamine derivative and use thereof as pharmaceutical
GB201905509D0
(en )
2019-06-05
Pharmaceutical compositions and associated lits and uses
EP3718543A4
(en )
2021-07-21
Pharmaceutical composition and use thereof
HK1254527A1
(en )
2019-07-19
Pharmaceutical formulation and use thereof
EP3763373A4
(en )
2021-05-12
Pharmaceutical formulation and use thereof
IL292646A
(en )
2022-07-01
Pharmaceutical combination and use thereof